Company Overview and News


Add RARE
to your dashboard

Headline News

Ultragenyx's rhGUS Gets FDA Nod for Rare Genetic Disease

2017-11-17 zacks
Ultragenyx Pharmaceutical Inc. (RARE - Free Report) announced that the FDA has approved its genetic disorder drug, vestronidase alfa or rhGUS, for treatment of children and adults with mucopolysaccharidosis VII (MPS VII, also known as Sly syndrome). It is approved under the trade name, MEPSEVII. (43-0)

Your Daily Pharma Scoop: A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tumbles

2017-11-16 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (381-2)

BRIEF-Ultragenyx completes patients dosing in first cohort of phase 1/2 study of DTX301

2017-11-16 reuters
* Ultragenyx announces completion of patient dosing in first cohort of phase 1/2 clinical study of dtx301 gene therapy in ornithine transcarbamylase (OTC) deficiency (12-0)

BRIEF-ULTRAGENYX SAYS FDA APPROVES MEPSEVII FOR GENETIC DISEASE MUCOPOLYSACCHARIDOSIS VII

2017-11-15 reuters
* ULTRAGENYX ANNOUNCES FDA APPROVAL OF MEPSEVII™ (VESTRONIDASE ALFA), THE FIRST THERAPY FOR PROGRESSIVE AND DEBILITATING RARE GENETIC DISEASE MUCOPOLYSACCHARIDOSIS VII (12-0)

FDA approves Ultragenyx drug for rare enzyme disorder

2017-11-15 channelnewsasia
REUTERS: The U.S. Food and Drug Administration approved on Wednesday a new treatment made by Ultragenyx Pharmaceutical Inc for a rare genetic disorder that can dramatically reduce life expectancy. (12-0)

UPDATE 1-U.S. FDA approves Ultragenyx drug for rare enzyme disorder

2017-11-15 reuters
(Reuters) - The U.S. Food and Drug Administration approved on Wednesday a new treatment made by Ultragenyx Pharmaceutical Inc for a rare genetic disorder that can dramatically reduce life expectancy. (12-0)

BRIEF-FDA approves Ultragenyx Pharmaceutical's Mepsevii for rare genetic enzyme disorder‍​

2017-11-15 reuters
* Approved Ultragenyx Pharma’s Mepsevii to treat pediatric, adult patients with inherited metabolic condition called mucopolysaccharidosis TYPE VII ‍​ Further company coverage: (12-0)

Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer

2017-11-15 zacks
With just a handful of biotech companies left to report third quarter results, focus is back on regulatory and pipeline updates. Among major news this week, Dynavax Technologies (DVAX - Free Report) finally gained FDA approval for its hepatitis B vaccine while Loxo Oncology (LOXO - Free Report) was in the news for its collaboration agreement with Bayer. Recap of the Week’s Most Important Stories Loxo down despite Bayer Deal worth Up To $1. (226-0)

Featured Company News - Deciphera Reported Data Analysis from the Ongoing Phase-1 Clinical Trial of DCC-2618 at the Annual Meeting of The Connective Tissue Oncology Society

2017-11-13 accesswire
LONDON, UK / ACCESSWIRE / November 13, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=DCPH. The Company announced on November 10, 2017, that it presented data analysis from its ongoing Phase-1 clinical trial of DCC-2618, the Company's pan-KIT and PDGFRα inhibitor, at the Annual Meeting of The Connective Tissue Oncology Society (CTOS) in Maui, Hawaii, USA. (27-0)

The Zacks Analyst Blog Highlights: Royal Caribbean, Macy's, Exxon Mobil, Intel and Mastercard

2017-11-07 zacks
Chicago, IL – November 7, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Royal Caribbean (RCL - Free Report) , Macy’s (M - Free Report) , Exxon Mobil (XOM - Free Report) , Intel (INTC - Free Report) and Mastercard (MA - Free Report) . (242-0)

The Zacks Analyst Blog Highlights: Facebook, Celgene, BlackRock, Danaher and BP

2017-11-07 zacks
Chicago, IL – November 7, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Facebook (FB - Free Report) , Celgene (CELG - Free Report) , BlackRock (BLK - Free Report) , Danaher (DHR - Free Report) and BP (BP - Free Report) . (288-0)

The Zacks Analyst Blog Highlights: Groupon, LSI Industries, Glu Mobile, Tesco and LimeLight Networks

2017-11-07 zacks
Chicago, IL – November 7, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Groupon, Inc. (GRPN - Free Report) , LSI Industries Inc. (LYTS - Free Report) , Glu Mobile Inc. (GLUU - Free Report) , Tesco PLC (TSCDY - Free Report) and LimeLight Networks, Inc. (181-0)

Zacks Industry Outlook Highlights: Oil & Gas, including ExxonMobil, Chevron, Royal Dutch Shell, BP and TOTAL

2017-11-07 zacks
Chicago, IL – November 7, 2017 – Today, Zacks Equity Research discusses the Oil & Gas, including ExxonMobil (XOM - Free Report) , Chevron (CVX - Free Report) , Royal Dutch Shell’s (RDS.A - Free Report) , BP plc (BP - Free Report) and TOTAL (TOT - Free Report) . (204-0)

Zacks.com featured highlights: PetMed Express, Microsoft, Rockwell Collins, Jones Lang LaSalle and Owens Corning

2017-11-07 zacks
Chicago, IL – November 7, 2017 - Stocks in this week’s article PetMed Express Inc. (PETS - Free Report) , Microsoft Corporation (MSFT - Free Report) , Rockwell Collins, Inc. (COL - Free Report) , Jones Lang LaSalle Incorporated (JLL - Free Report) and Owens Corning Inc. (OC - Free Report) . (196-0)

Zacks.com featured highlights: WellCare Health Plans, Boston Beer Company, Adobe Systems and Take Two Interactive Software

2017-11-07 zacks
Chicago, IL – November 7, 2017 - Stocks in this week’s article WellCare Health Plans Inc. (WCG - Free Report) , Boston Beer Company Inc. (SAM - Free Report) , Adobe Systems Inc. (ADBE - Free Report) and Take Two Interactive Software Inc (TTWO - Free Report) . (210-0)

CUSIP: 90400D108